Drug intelligence / Profile preview

调免I号

Development stage
Unknown
Lead developer
Guanghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Administration
Oral
01

Overview

调免I号 (Tiaomian No. 1) is a specialized Traditional Chinese Medicine (TCM) hospital-made preparation developed by the Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine. It is primarily indicated for the treatment of Systemic Lupus Erythematosus (SLE), particularly during the active phase characterized by Yin deficiency and internal heat in TCM theory. The formula consists of several botanical ingredients, including Rehmannia glutinosa and Scrophularia buergeriana, which work synergistically to modulate the immune system. Research indicates that 调免I号 functions by inhibiting the production of pro-inflammatory cytokines such as IL-6 and TNF-alpha, and by restoring the balance between Th17 and Treg cell populations, thereby reducing the autoimmune inflammatory response and protecting organ function.

Other names
Tiaomian I HaoTiaomian MixtureTiaomian Heji

Beyond the preview

Go deeper on 调免I号.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 调免I号.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call